Has Srinivas Tummala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $138,980 in general payments to Srinivas Tummala, MD across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Srinivas Tummala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Srinivas Tummala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Srinivas Tummala, MD

Vascular & Interventional Radiology · Pembroke Pines, FLNPI 1922083120

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $112,895 of the $138,980 with a category attached, or 81.2%. Abbott accounts for 80.9% of it on its own, with 20 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$138,980in general payments, 2019–2025

Across 158 payments — averaging $879.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$112K
Bard Peripheral Vascular, Inc.$17K
Cardiovascular Systems Inc.$5K
Philips North America LLC$2K
Terumo Medical Corporation$624
Asahi Intecc USA, Inc.$546
plus $2K from 15 others

What the payments were for

Consulting fees$112,89581%
Speaking & faculty fees$15,88011%
Travel & lodging$3,1112%
Food & beverage$7,0795%
Education$160%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	89	$112,427
Bard Peripheral Vascular, Inc.	16	$16,611
Cardiovascular Systems Inc.	3	$5,400
Philips North America LLC	1	$1,500
Terumo Medical Corporation	3	$624
Asahi Intecc USA, Inc.	13	$546
Avinger Inc.	8	$400
Boston Scientific	6	$343
Vasorum USA Inc.	1	$142
Dilon Technologies, Inc.	2	$142
Inari Medical, Inc.	1	$140
Balt USA, LLC	3	$135
W. L. Gore & Associates, Inc.	1	$111
Penumbra, Inc.	1	$103
Celonova Biosciences, Inc.	1	$100
Angiodynamics, Inc.	2	$86
Shockwave Medical, Inc	2	$78
BD	2	$34
Medtronic	1	$22
AstraZeneca	1	$20
Biotronik Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Omnilink Elite vascular stent system$32,304
Perclose ProStyle$27,225
SUPERA$16,429
PERCLOSE PROGLIDE$16,162
OMNILINK ELITE$12,577
LUTONIX$12,105
Diamondback Coronary$5,400
Diamondback Peripheral$5,400
ESPRIT$4,901
(9520) IGT Devices Undivided$1,500
Misago$250
Indigo$206
JETI$165
NAVITOR$161
PROSTAR$156
CELT ACD$142
FlowTriever$140
ClotTriever$140
GENERAL VASCULAR INTERVENTION$139
VIABAHN Endoprosthesis$111

How this compares

$138,980 in reported general payments places this provider in the 90th percentile of 329 vascular & interventional radiology providers in Florida.

See all vascular & interventional radiology providers in Florida →

Medicare billing

Part B allowed, 2024

$257,860

Medicare patients

Services billed

359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	15	$166

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Pembroke Pines

Ripal GandhiMiami$2.5M
Michael CohnHollywood$1.3M
Bret WiechmannGainesville$1.3M
George OliveiraMiami$666K
Fakhir ElmasriLakeland$563K
Shaun PatelCoral Gables$458K
Justin LeeTampa$408K
Timothy YatesMiami Beach$392K
Rishi RazdanJacksonville$378K
Govindarajan NarayananMiami$343K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →